Skip to main content

Table 1 Comparison of the reported diseases between 11 validated MRESS SNPs and their corresponding interactions

From: Genome-wide association study combined with biological context can reveal more disease-related SNPs altering microRNA target seed sites

SNP ID

Interaction

Reported disease of SNP

Reported disease of interaction

rs1042538

IQGAP1::hsa-miR-124

Breast cancer*

Breast neoplasms*/prostatic neoplasms/colorectal neoplasms…

rs1054190

NR1I2::hsa-miR-148a

Primary sclerosing cholangitis**

Hepatocellular carcinoma**/leukemia…

rs1056628

MMP9::hsa-miR-491-5p

Atherosclerotic cerebral infarction*

Cerebral infarction*/multiple sclerosis…

rs1057233

SPI1::hsa-miR-569

Systemic lupus erythematosus*

Systemic lupus erythematosus*

rs1063320

HLA-G:: hsa-miR-152

Multiple sclerosis**/systemic lupus erythematosus/pre-eclampsia*/HCV infection

Atherosclerosis**/pre-eclampsia*/asthma…

rs11574744

HNF4A:: hsa-miR-34a/34c-5p

Diabetes**/renal cell carcinoma*

Metabolic diseases**/renal cell carcinoma*/coronary artery disease/alcoholic fatty liver…

rs12720208

FGF20:: hsa-miR-433

Parkinson’s disease*

Parkinson’s disease*/ovarian neoplasms…

rs1621

MET:: hsa-miR-199a-3p

Chronic rhinosinusitis

Atrophic muscular disorders/Crohn’s disease…

rs16917496

SETD8:: hsa-miR-502-5p

Breast cancer/small-cell lung cancer/*epithelial ovarian cancer/*hepatocellular carcinoma

Ovarian neoplasms*/hepatocellular carcinoma*

rs28521337

NTRK3:: hsa-miR-485-3p

Anxiety disorders

Asthma/hepatocellular carcinoma/leukemia…

rs5186

AGTR1:: hsa-miR-155

Renal disease*/hypertension*/inflammation*/pre-eclampsia*/type 2 diabetes*/mountain sickness/diastolic heart failure/*hypertrophic cardiomyopathy**/aldosterone-producing adenoma**

Renal insufficiency**/kidney diseases*/hypertension*/inflammation*/pre-eclampsia*/diabetes mellitus*/diabetes complications/heart failure*/adenocarcinoma**…

  1. *Diseases that exactly matched between the two blanks.
  2. **Diseases that matched at a broad level (e.g. diabetes vs. metabolic diseases).